Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

NuCana plc American Depositary Share

NCNA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of NCNA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
NCNA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
NCNA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NCNA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in NCNA holdings by institutional investors

Quarterly net insider trading by NCNA's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for NCNA

Quiver Logo

No former government officials on record as having lobbied for NCNA

Revolving Door Dashboard

NCNA Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

NCNA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
NCNA Income Statement
NCNA Balance Sheet
NCNA Cash Flow
U.S. Patents

New NCNA patent grants

  • Patent Title: Formulations of phosphoramidate derivatives of nucleoside drugs Jul. 15, 2025
  • Patent Title: Synthesis of phosphate derivatives Aug. 06, 2024
  • Patent Title: 2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds Aug. 06, 2024
  • Patent Title: Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancer Mar. 12, 2024
  • Patent Title: Synthesis of 3′-deoxyadenosine-5′-o-[phenyl(benzyloxy-l-alaninyl)]phosphate (nuc-738) Feb. 13, 2024
  • Patent Title: Formulations of phosphoramidate derivatives of nucleoside drugs Oct. 17, 2023
  • Patent Title: Formulation comprising a gemcitabine-prodrug Jul. 25, 2023
  • Patent Title: Gemcitabine prodrugs Apr. 18, 2023
  • Patent Title: Diastereoselective synthesis of phosphate derivatives Mar. 14, 2023
  • Patent Title: Salts of diphosphate phosphoramidate of nucleosides as anticancer compounds Jan. 24, 2023
  • Patent Title: Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer Jan. 24, 2023
  • Patent Title: Synthesis of phosphate derivatives Aug. 16, 2022
  • Patent Title: Floxuridine synthesis Aug. 16, 2022
  • Patent Title: Cancer treatments Aug. 02, 2022
  • Patent Title: Crystalline form of gemcitabine Jul. 05, 2022
  • Patent Title: 2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds Jun. 07, 2022
  • Patent Title: Process for preparing nucleoside prodrugs Jun. 22, 2021
  • Patent Title: Formulation comprising a gemcitabine-prodrug Jun. 22, 2021
  • Patent Title: Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer May. 04, 2021
  • Patent Title: Phosphoramidate nucleoside derivatives as anticancer agents Feb. 02, 2021
  • Patent Title: Formulation comprising a gemcitabine-prodrug Sep. 29, 2020
  • Patent Title: Methods of separating gemcitabine-phosphate diastereoisomers Jun. 02, 2020
  • Patent Title: Gemcitabine prodrugs May. 26, 2020
  • Patent Title: Combination therapy for cancer May. 26, 2020
  • Patent Title: 2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti- cancer compounds Feb. 25, 2020
  • Patent Title: Phosphoramidate compounds and methods of use Sep. 03, 2019
  • Patent Title: Formulation comprising a gemcitabine-prodrug Nov. 06, 2018
  • Patent Title: Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer Jul. 17, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to NCNA from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
NCNA News

Recent insights relating to NCNA

CNBC Recommendations

Recent picks made for NCNA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NCNA

NCNA Analyst Ratings

NCNA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
NCNA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $NCNA stock a Buy, Sell, or Hold?

  • What is the price target for $NCNA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

NCNA Top Shareholders
Shareholder
Shares Held
NCNA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $NCNA stock?

  • Who owns the most shares of $NCNA stock?

  • What funds own $NCNA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NCNA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NCNA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About NCNA

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.

NuCana plc American Depositary Share (NCNA) Historical Stock Prices

NuCana plc American Depositary Share (NCNA) closed at $1.31 on September 23, 2026. Over the past year its adjusted close ranged from $1.21 to $7.02. Daily prices go back to September 28, 2017, 2,256 trading days in all.

  • 1 month-10.88%
  • 3 months-20.12%
  • Year to date-63.61%
  • 1 year-66.32%
  • 3 years-99.96%
  • 5 years-99.99%
  • Max-100.00%
See every congressional and insider trade on the NCNA price chart

Quiver Premium charts NCNA's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 1.33 1.35 1.30 1.31 1.31 27,843
Sep 22, 2026 1.35 1.38 1.30 1.33 1.33 20,545
Sep 21, 2026 1.35 1.39 1.32 1.32 1.32 26,375
Sep 18, 2026 1.33 1.39 1.32 1.34 1.34 10,972
Sep 17, 2026 1.33 1.37 1.30 1.33 1.33 47,242
Sep 16, 2026 1.31 1.33 1.30 1.30 1.30 19,203
Sep 15, 2026 1.32 1.35 1.30 1.30 1.30 65,812
Sep 14, 2026 1.34 1.37 1.31 1.32 1.32 13,689
Sep 11, 2026 1.34 1.36 1.32 1.32 1.32 25,116
Sep 10, 2026 1.36 1.38 1.34 1.34 1.34 27,028
Sep 9, 2026 1.40 1.44 1.37 1.37 1.37 17,195
Sep 8, 2026 1.42 1.43 1.40 1.40 1.40 21,656
Sep 4, 2026 1.41 1.42 1.38 1.40 1.40 32,172
Sep 3, 2026 1.38 1.44 1.36 1.43 1.43 49,928
Sep 2, 2026 1.38 1.43 1.33 1.39 1.39 50,782
Sep 1, 2026 1.44 1.45 1.35 1.38 1.38 103,950
Aug 31, 2026 1.55 1.55 1.44 1.47 1.47 193,102
Aug 28, 2026 1.45 1.90 1.41 1.76 1.76 1,018,257
Aug 27, 2026 1.50 1.51 1.44 1.47 1.47 17,399
Aug 26, 2026 1.48 1.53 1.47 1.53 1.53 13,018
Aug 25, 2026 1.47 1.55 1.47 1.47 1.47 26,735
Aug 24, 2026 1.52 1.52 1.47 1.47 1.47 13,411
Aug 21, 2026 1.50 1.55 1.50 1.52 1.52 18,574
Aug 20, 2026 1.53 1.55 1.50 1.53 1.53 18,408
Aug 19, 2026 1.53 1.66 1.51 1.55 1.55 26,675
Aug 18, 2026 1.55 1.59 1.52 1.52 1.52 17,665
Aug 17, 2026 1.64 1.64 1.51 1.55 1.55 53,156
Aug 14, 2026 1.49 1.67 1.49 1.59 1.59 70,878
Aug 13, 2026 1.42 1.49 1.42 1.48 1.48 15,668
Aug 12, 2026 1.51 1.51 1.40 1.43 1.43 18,347
Aug 11, 2026 1.42 1.59 1.41 1.44 1.44 34,519
Aug 10, 2026 1.53 1.53 1.43 1.44 1.44 22,099
Aug 7, 2026 1.36 1.66 1.34 1.47 1.47 206,785
Aug 6, 2026 1.31 1.37 1.28 1.36 1.36 15,518
Aug 5, 2026 1.39 1.39 1.30 1.34 1.34 25,945
Aug 4, 2026 1.37 1.40 1.36 1.39 1.39 11,393
Aug 3, 2026 1.32 1.38 1.32 1.35 1.35 26,662
Jul 31, 2026 1.27 1.34 1.25 1.32 1.32 24,650
Jul 30, 2026 1.23 1.26 1.23 1.26 1.26 9,193
Jul 29, 2026 1.26 1.29 1.21 1.21 1.21 27,854
Jul 28, 2026 1.26 1.29 1.25 1.29 1.29 12,756
Jul 27, 2026 1.36 1.36 1.25 1.26 1.26 26,646
Jul 24, 2026 1.33 1.33 1.29 1.29 1.29 4,501
Jul 23, 2026 1.38 1.41 1.31 1.33 1.33 20,306
Jul 22, 2026 1.29 1.40 1.29 1.36 1.36 49,013
Jul 21, 2026 1.29 1.33 1.28 1.29 1.29 15,410
Jul 20, 2026 1.31 1.31 1.21 1.31 1.31 85,074
Jul 17, 2026 1.30 1.38 1.28 1.31 1.31 39,479
Jul 16, 2026 1.35 1.39 1.31 1.33 1.33 31,754
Jul 15, 2026 1.32 1.35 1.30 1.35 1.35 34,884
Jul 14, 2026 1.29 1.34 1.28 1.31 1.31 94,318
Jul 13, 2026 1.35 1.36 1.26 1.28 1.28 41,054
Jul 10, 2026 1.23 1.49 1.23 1.34 1.34 98,220
Jul 9, 2026 1.33 1.40 1.21 1.24 1.24 209,984
Jul 8, 2026 1.40 1.40 1.32 1.32 1.32 103,335
Jul 7, 2026 1.45 1.45 1.37 1.39 1.39 43,221
Jul 6, 2026 1.44 1.48 1.38 1.39 1.39 45,258
Jul 2, 2026 1.47 1.55 1.36 1.36 1.36 179,284
Jul 1, 2026 1.53 1.59 1.41 1.44 1.44 60,893
Jun 30, 2026 1.61 1.62 1.52 1.52 1.52 22,995
Jun 29, 2026 1.61 1.68 1.51 1.58 1.58 41,650
Jun 26, 2026 1.58 1.62 1.43 1.55 1.55 81,929
Jun 25, 2026 1.62 1.69 1.60 1.60 1.60 26,134
Jun 24, 2026 1.75 1.79 1.62 1.64 1.64 44,207
Jun 23, 2026 1.78 1.96 1.67 1.73 1.73 47,589
Jun 22, 2026 1.90 1.93 1.82 1.83 1.83 28,055
Jun 18, 2026 1.91 1.96 1.84 1.91 1.91 42,383
Jun 17, 2026 1.81 1.90 1.78 1.86 1.86 19,183
Jun 16, 2026 1.96 1.96 1.78 1.79 1.79 53,430
Jun 15, 2026 2.01 2.05 1.91 1.92 1.92 35,178
Jun 12, 2026 2.05 2.20 1.90 1.95 1.95 74,141
Jun 11, 2026 1.94 2.01 1.81 1.99 1.99 186,298
Jun 10, 2026 1.98 1.99 1.95 1.95 1.95 25,885
Jun 9, 2026 2.03 2.08 1.96 1.97 1.97 55,537
Jun 8, 2026 1.96 2.08 1.96 2.05 2.05 22,955
Jun 5, 2026 2.07 2.07 1.91 1.95 1.95 44,811
Jun 4, 2026 2.01 2.12 2.01 2.02 2.02 43,223
Jun 3, 2026 2.03 2.19 2.03 2.03 2.03 14,687
Jun 2, 2026 2.10 2.22 2.03 2.07 2.07 50,479
Jun 1, 2026 2.25 2.29 2.15 2.17 2.17 28,515
May 29, 2026 2.17 2.39 2.15 2.33 2.33 30,790
May 28, 2026 2.05 2.39 2.05 2.27 2.27 126,802
May 27, 2026 2.03 2.17 1.98 2.15 2.15 49,433
May 26, 2026 1.97 2.04 1.97 2.00 2.00 21,315
May 22, 2026 2.06 2.08 2.01 2.02 2.02 25,416
May 21, 2026 1.98 2.07 1.95 2.03 2.03 27,515
May 20, 2026 2.00 2.08 1.99 2.04 2.04 13,826
May 19, 2026 2.02 2.10 1.96 1.98 1.98 15,247
May 18, 2026 2.21 2.21 1.98 2.03 2.03 47,146
May 15, 2026 2.03 2.31 2.03 2.18 2.18 130,354
May 14, 2026 1.95 2.14 1.86 1.98 1.98 62,031
May 13, 2026 1.85 1.91 1.85 1.87 1.87 16,189
May 12, 2026 1.95 2.00 1.86 1.86 1.86 27,296
May 11, 2026 2.07 2.14 1.83 1.97 1.97 111,766
May 8, 2026 2.10 2.23 2.10 2.11 2.11 25,073
May 7, 2026 2.23 2.27 2.05 2.09 2.09 37,532
May 6, 2026 2.18 2.28 2.11 2.21 2.21 22,614
May 5, 2026 2.23 2.29 2.14 2.19 2.19 33,283
May 4, 2026 2.14 2.25 2.14 2.21 2.21 27,561
May 1, 2026 2.09 2.27 2.09 2.25 2.25 28,153
Apr 30, 2026 2.06 2.16 2.04 2.13 2.13 11,810
Apr 29, 2026 2.12 2.19 2.02 2.04 2.04 37,901
Apr 28, 2026 2.16 2.19 2.12 2.15 2.15 15,931
Apr 27, 2026 2.04 2.24 2.04 2.21 2.21 53,545
Apr 24, 2026 2.10 2.12 2.01 2.06 2.06 21,171
Apr 23, 2026 2.13 2.17 2.09 2.15 2.15 12,342
Apr 22, 2026 2.17 2.19 2.12 2.13 2.13 16,914
Apr 21, 2026 2.29 2.29 2.13 2.17 2.17 14,319
Apr 20, 2026 2.25 2.33 2.20 2.29 2.29 33,262
Apr 17, 2026 2.27 2.33 2.16 2.25 2.25 26,672
Apr 16, 2026 2.20 2.20 2.12 2.13 2.13 21,479
Apr 15, 2026 2.22 2.22 2.16 2.18 2.18 24,602
Apr 14, 2026 2.07 2.20 2.07 2.16 2.16 20,994
Apr 13, 2026 2.00 2.17 1.98 2.06 2.06 37,331
Apr 10, 2026 2.13 2.18 1.95 1.97 1.97 46,474
Apr 9, 2026 1.92 2.26 1.92 2.10 2.10 104,818
Apr 8, 2026 1.98 1.98 1.82 1.90 1.90 44,773
Apr 7, 2026 1.69 2.13 1.66 2.05 2.05 133,801
Apr 6, 2026 1.59 1.72 1.59 1.68 1.68 24,367
Apr 2, 2026 1.54 1.67 1.42 1.63 1.63 18,828
Apr 1, 2026 1.41 1.59 1.41 1.54 1.54 30,533
Mar 31, 2026 1.45 1.45 1.37 1.40 1.40 43,325
Mar 30, 2026 1.42 1.50 1.33 1.34 1.34 39,601
Mar 27, 2026 1.49 1.52 1.39 1.40 1.40 57,397
Mar 26, 2026 1.52 1.54 1.48 1.48 1.48 22,291
Mar 25, 2026 1.55 1.58 1.42 1.53 1.53 152,227
Mar 24, 2026 1.65 1.69 1.59 1.59 1.59 26,670
Mar 23, 2026 1.63 1.73 1.62 1.66 1.66 37,435
Mar 20, 2026 1.70 1.75 1.63 1.65 1.65 46,231
Mar 19, 2026 1.67 1.75 1.63 1.71 1.71 52,662
Mar 18, 2026 1.85 1.89 1.74 1.74 1.74 71,770
Mar 17, 2026 1.88 1.96 1.85 1.86 1.86 55,520
Mar 16, 2026 1.91 2.00 1.88 1.90 1.90 43,440
Mar 13, 2026 2.02 2.08 1.89 1.91 1.91 45,211
Mar 12, 2026 1.99 2.01 1.93 1.99 1.99 43,361
Mar 11, 2026 2.03 2.09 1.90 1.95 1.95 65,394
Mar 10, 2026 1.98 2.11 1.98 2.01 2.01 26,880
Mar 9, 2026 2.16 2.19 1.90 1.95 1.95 69,164
Mar 6, 2026 2.02 2.21 2.00 2.16 2.16 103,548
Mar 5, 2026 2.13 2.22 1.95 1.96 1.96 59,596
Mar 4, 2026 2.15 2.22 2.07 2.13 2.13 23,673
Mar 3, 2026 2.08 2.20 2.00 2.15 2.15 46,573
Mar 2, 2026 2.13 2.19 2.08 2.15 2.15 19,530
Feb 27, 2026 2.17 2.17 2.08 2.16 2.16 8,723
Feb 26, 2026 2.16 2.23 2.12 2.19 2.19 20,622
Feb 25, 2026 2.20 2.27 2.15 2.24 2.24 26,724
Feb 24, 2026 2.07 2.21 2.07 2.14 2.14 37,747
Feb 23, 2026 2.09 2.13 2.00 2.06 2.06 21,641
Feb 20, 2026 2.14 2.20 2.09 2.10 2.10 19,154
Feb 19, 2026 2.15 2.15 2.09 2.15 2.15 20,660
Feb 18, 2026 2.03 2.19 2.01 2.11 2.11 20,257
Feb 17, 2026 2.13 2.18 2.00 2.00 2.00 54,613
Feb 13, 2026 2.10 2.25 2.10 2.12 2.12 23,962
Feb 12, 2026 2.23 2.26 2.08 2.08 2.08 36,160
Feb 11, 2026 2.24 2.25 2.13 2.19 2.19 28,781
Feb 10, 2026 2.27 2.28 2.22 2.23 2.23 25,813
Feb 9, 2026 2.22 2.33 2.21 2.25 2.25 28,330
Feb 6, 2026 2.15 2.26 2.10 2.22 2.22 62,508
Feb 5, 2026 2.33 2.33 2.07 2.09 2.09 82,097
Feb 4, 2026 2.41 2.46 2.28 2.38 2.38 54,521
Feb 3, 2026 2.57 2.67 2.35 2.40 2.40 107,868
Feb 2, 2026 2.44 2.60 2.42 2.58 2.58 73,563
Jan 30, 2026 2.68 2.73 2.47 2.51 2.51 91,756
Jan 29, 2026 2.94 2.94 2.67 2.71 2.71 166,994
Jan 28, 2026 2.97 3.01 2.91 2.95 2.95 51,082
Jan 27, 2026 3.13 3.13 2.89 2.95 2.95 77,708
Jan 26, 2026 3.23 3.23 3.08 3.10 3.10 103,548
Jan 23, 2026 3.25 3.34 3.22 3.26 3.26 37,895
Jan 22, 2026 3.27 3.35 3.21 3.22 3.22 44,236
Jan 21, 2026 3.19 3.32 3.16 3.25 3.25 58,162
Jan 20, 2026 3.30 3.30 3.14 3.21 3.21 70,574
Jan 16, 2026 3.34 3.50 3.25 3.31 3.31 151,715
Jan 15, 2026 3.30 3.38 3.27 3.34 3.34 58,230
Jan 14, 2026 3.46 3.49 3.33 3.33 3.33 52,023
Jan 13, 2026 3.25 3.81 3.25 3.53 3.53 463,301
Jan 12, 2026 3.33 3.39 3.27 3.30 3.30 48,845
Jan 9, 2026 3.60 3.66 3.37 3.37 3.37 66,158
Jan 8, 2026 3.64 3.72 3.60 3.60 3.60 17,940
Jan 7, 2026 3.61 3.73 3.61 3.62 3.62 49,129
Jan 6, 2026 3.65 3.77 3.50 3.70 3.70 80,842
Jan 5, 2026 3.63 3.73 3.56 3.70 3.70 80,890
Jan 2, 2026 3.60 3.78 3.60 3.64 3.64 55,571
Dec 31, 2025 3.48 3.65 3.46 3.60 3.60 53,579
Dec 30, 2025 3.50 3.58 3.34 3.53 3.53 80,121
Dec 29, 2025 3.30 3.46 3.21 3.46 3.46 147,015
Dec 26, 2025 3.20 3.38 3.16 3.31 3.31 66,394
Dec 24, 2025 3.31 3.42 3.26 3.34 3.34 34,788
Dec 23, 2025 3.38 3.48 3.30 3.31 3.31 50,977
Dec 22, 2025 3.47 3.56 3.41 3.41 3.41 50,392
Dec 19, 2025 3.45 3.58 3.43 3.56 3.56 52,039
Dec 18, 2025 3.42 3.58 3.39 3.47 3.47 23,828
Dec 17, 2025 3.53 3.53 3.30 3.43 3.43 84,242
Dec 16, 2025 3.50 3.64 3.46 3.56 3.56 41,238
Dec 15, 2025 3.75 3.82 3.62 3.62 3.62 35,371
Dec 12, 2025 4.08 4.09 3.70 3.72 3.72 67,626
Dec 11, 2025 4.25 4.25 3.95 4.05 4.05 73,430
Dec 10, 2025 4.45 4.55 4.03 4.27 4.27 101,750
Dec 9, 2025 4.20 4.34 4.15 4.28 4.28 34,284
Dec 8, 2025 4.16 4.26 4.09 4.14 4.14 45,477
Dec 5, 2025 4.45 4.54 4.16 4.17 4.17 54,806
Dec 4, 2025 4.19 4.48 4.14 4.43 4.43 45,477
Dec 3, 2025 4.00 4.34 4.00 4.24 4.24 65,669
Dec 2, 2025 4.01 4.01 3.82 3.98 3.98 21,804
Dec 1, 2025 4.16 4.16 3.97 4.00 4.00 39,677
Nov 28, 2025 3.99 4.35 3.99 4.28 4.28 78,598
Nov 26, 2025 3.88 4.06 3.82 3.97 3.97 44,746
Nov 25, 2025 3.80 3.94 3.70 3.85 3.85 73,087
Nov 24, 2025 3.50 3.84 3.50 3.80 3.80 70,451
Nov 21, 2025 3.48 3.60 3.38 3.50 3.50 69,390
Nov 20, 2025 3.33 3.88 3.33 3.56 3.56 151,444
Nov 19, 2025 3.30 3.37 3.22 3.35 3.35 33,643
Nov 18, 2025 3.16 3.38 3.10 3.31 3.31 53,217
Nov 17, 2025 3.30 3.39 3.20 3.20 3.20 135,424
Nov 14, 2025 3.24 3.53 3.24 3.41 3.41 48,634
Nov 13, 2025 3.72 3.80 3.30 3.49 3.49 149,846
Nov 12, 2025 3.60 3.86 3.60 3.79 3.79 57,080
Nov 11, 2025 3.70 3.75 3.61 3.72 3.72 36,799
Nov 10, 2025 3.80 3.85 3.61 3.67 3.67 50,995
Nov 7, 2025 3.57 3.90 3.55 3.68 3.68 48,651
Nov 6, 2025 3.86 3.88 3.57 3.64 3.64 60,092
Nov 5, 2025 3.82 3.89 3.64 3.80 3.80 88,690
Nov 4, 2025 3.75 3.92 3.61 3.63 3.63 90,424
Nov 3, 2025 4.04 4.04 3.83 3.94 3.94 81,604
Oct 31, 2025 3.80 4.07 3.80 4.01 4.01 75,491
Oct 30, 2025 3.86 3.92 3.71 3.71 3.71 113,441
Oct 29, 2025 4.05 4.19 3.90 3.95 3.95 102,518
Oct 28, 2025 4.25 4.38 4.13 4.20 4.20 91,830
Oct 27, 2025 4.20 4.38 4.20 4.32 4.32 81,051
Oct 24, 2025 4.19 4.41 4.19 4.26 4.26 90,229
Oct 23, 2025 3.97 4.26 3.97 4.19 4.19 96,852
Oct 22, 2025 4.10 4.12 3.81 4.02 4.02 299,690
Oct 21, 2025 4.98 4.98 4.17 4.21 4.21 499,735
Oct 20, 2025 5.24 5.65 4.94 4.97 4.97 1,939,784
Oct 17, 2025 5.01 5.34 5.01 5.07 5.07 175,160
Oct 16, 2025 5.42 5.58 5.00 5.14 5.14 173,462
Oct 15, 2025 5.80 6.10 5.29 5.36 5.36 213,335
Oct 14, 2025 5.70 5.99 5.27 5.85 5.85 367,177
Oct 13, 2025 5.83 6.16 5.66 5.78 5.78 462,349
Oct 10, 2025 5.97 6.17 5.20 5.33 5.33 340,716
Oct 9, 2025 5.83 6.40 5.73 5.94 5.94 328,624
Oct 8, 2025 6.56 6.65 5.49 5.91 5.91 866,124
Oct 7, 2025 5.16 7.22 5.02 7.02 7.02 2,689,652
Oct 6, 2025 4.76 5.39 4.54 5.08 5.08 599,055
Oct 3, 2025 4.59 5.05 4.59 4.68 4.68 375,384
Oct 2, 2025 4.79 5.07 4.50 4.63 4.63 418,222
Oct 1, 2025 4.42 5.04 4.42 4.86 4.86 622,357
Sep 30, 2025 3.85 5.18 3.79 4.64 4.64 3,940,834
Sep 29, 2025 3.97 4.10 3.80 3.83 3.83 228,930
Sep 26, 2025 3.92 4.10 3.87 4.01 4.01 148,104
Sep 25, 2025 4.01 4.09 3.85 3.98 3.98 150,424
Sep 24, 2025 3.93 4.20 3.91 4.15 4.15 375,900
Sep 23, 2025 3.97 4.15 3.81 3.89 3.89 240,628

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
NuCana plc American Depositary Share Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at NCNA, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation